Release Date: 06/04/22 12:00 Summary: Units on Issue Disclosure - Mar 2022 Price Sensitive: No Download Document 156.02KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%